Semaglutide is FDA-approved for the treatment of type 2 diabetes
Tirzepatide is one such molecule that has shown marked glycemia and weight benefits in a series of trials 5,6
doi: 10.1210/clinem/dgaa863 Summary Keywords obesity, insulin-resistance, Tirzepatide, pathophysiology, GIP, GLP - 1, clinical trials, arterial hypertension Citation Corrao S, Pollicino C, Maggio D, Torres A and Argano C (2024) Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence
Unfortunately, theres no magic pill to stop every kind of stomach upset
For those concerned about potential long-term side effects, Hughes notes that while GLP-1 drugs are new players in combating obesity, theyve been around for 20 years for diabetes management
They are related to diet or lifestyle habits